Insiders at covid-19 vaccine makers sold nearly $500 million of stock last year

- Executives at Moderna, Merck are among those who have reaped the biggest rewards
Executives and directors at Pfizer Inc., Moderna Inc. and other companies developing Covid-19 vaccines sold approximately $496 million of stock last year, reaping rewards of positive vaccine developments that drove up the value of the drugmakers’ shares.